4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-22-016047
Executive Vice President gave up 21,925 shares (to pay taxes)
- Executive Vice President acquired 43,716 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BOYER ANDREW S Executive Vice President | 2022-03-01 | Option exercise | +12,346 | 178,836 | D | ||
| BOYER ANDREW S Executive Vice President | 2022-03-01 | Shares withheld for taxes | −6,192 | $4.45 | $27,554 | 172,644 | D |
| BOYER ANDREW S Executive Vice President | 2022-03-01 | Option exercise | +31,370 | 204,014 | D | ||
| BOYER ANDREW S Executive Vice President | 2022-03-01 | Shares withheld for taxes | −15,733 | $4.45 | $70,012 | 188,281 | D |
| Derivatives | |||||||
| BOYER ANDREW S Executive Vice President | 2022-03-01 | Option exercise · Restricted Stock Units | −12,346 | 12,346 | D | ||
| BOYER ANDREW S Executive Vice President | 2022-03-01 | Option exercise · Restricted Stock Units | −31,370 | 94,113 | D | ||
| BOYER ANDREW S Executive Vice President | 2022-03-03 | Grant or award · Restricted Stock Units | +157,005 | 157,005 | D | ||
| BOYER ANDREW S Executive Vice President | 2022-03-03 | Grant or award · Performance-Based Restricted Stock Units | +314,010 | 314,010 | D | ||
Loading xslF345X03/doc4.xml…